Kai-Michael Beeh

9PUBLICATIONS
20CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingDisease surveillanceMedical biotechnology diagnostics (incl. biosensors)Time-series analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 08, 2026
A multicentre, observational prospective study to characterise the use of inhaled triple therapy for COPD: TETRIS final results after a 24-month follow-up period.

|Dec 10, 2025
Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study.

Kai M Beeh, Tim Harrison, Enrico Heffler

|Jul 13, 2025
Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis.

Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler

|Jun 24, 2025
Cost-Effectiveness of Single-Inhaler Versus Multiple-Inhaler Triple Therapy in COPD: A German Healthcare Perspective.

Kai-Michael Beeh, Jing Claussen, Dhvani Shah

|Oct 22, 2024
Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany.

Claus F Vogelmeier, Kai-Michael Beeh, Peter Kardos

|Aug 14, 2024
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study.

Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze

Pageof 2

Frequent Collaborators

5 joint publications

Jing Claussen

4 joint publications

Afisi S Ismaila

3 joint publications

Chris Compton

2 joint publications

Robyn Kendall